What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?
Cardiovascular Diabetology 2012, 11:32 doi:10.1186/1475-2840-11-32
- Last 30 days: 662 accesses
- Last 365 days: 6423 accesses
- All time: 29612 accesses
These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information